Drugs / Autologous adipose derived stem cells
Autologous adipose derived stem cells
also known as
Celltex AdMSCs · adipose-derived stem cells · adipose-derived stromal cells · AdMSCs · ASCs
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01585857 | Apr 2012 → Dec 2014 | osteoarthritis | University Hospital, Montpellier | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04170426 | Dec 2023 → Dec 2024 overdue | rheumatoid arthritis | Celltex Therapeutics Corporation | Not yet recruiting | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT04428801 | Sep 2023 → Sep 2024 overdue | COVID-19 | Celltex Therapeutics Corporation | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT04553159 | Mar → Jun 2021 | keloid | Makerere University | Completed | No outcome recorded |
| Phase 2 | NCT01799694 | Jul 2011 → Feb 2013 | — | Instituto de Investigación Hospital Universitario La Paz | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous adipose derived stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04553159 ↗ |
| Known as | adipose-derived stem cells | “Although this phase I study included a limited number of patients without a placebo arm, it showed that local injection of autologous adipose-derived stem cells was safe and...” PMID 27217345 ↗ May 2016 |
| Known as | adipose-derived stromal cells | “The present study aimed at evaluating the safety of a dose-escalation protocol of intra-articular injected adipose-derived stromal cells (ASCs) in patients with knee OA, as...” PMID 27217345 ↗ May 2016 |
| Known as | AdMSCs | “Phase 1/2a Clinical Study for Subjects With Rheumatoid Arthritis (RA) Using Multiple Dose Intravenous Infusions of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs)” NCT04170426 ↗ |
| Known as | ASCs | “The present study aimed at evaluating the safety of a dose-escalation protocol of intra-articular injected adipose-derived stromal cells (ASCs) in patients with knee OA, as...” PMID 27217345 ↗ May 2016 |
| Known as | Celltex AdMSCs | “using intravenous injection of autologous adipose stem cells (Celltex AdMSCs) for rheumatoid arthritis patients.” NCT04170426 ↗1“Other Names: Celltex-AdMSCs Celltex-AdMSCs” NCT04428801 ↗ |
| Modality | Cell therapy | “Culture expanded mesenchymal stem cells isolated from patient's own abdominal fat tissue” NCT04170426 ↗ |
| Route | Other | “intra-articular injection of autologous ASCs” PMID 27217345 ↗ May 2016 |